Using qPCR, we found tumor tissue samples positive for KRAS mutations in 44/146 samples (30%) and NRAS mutations in 10/146 (7%) (Table 1; supplementary Table S6, available at Annals of Oncology online). This evidence concerns the gene NRAS and neoplasm.